Unlocking the Power of PharmacovigilanceDownload Now
The idea that controlled clinical trials can establish product safety and effectiveness is a core principle of the pharmaceutical industry. Neither the clinical trials process nor the approval procedures of the FDA, however, can provide a perfect guarantee of safety for all potential consumers under all circumstances. Despite this fact, there are viable solutions that pharmaceutical companies can implement to support pharmacovigilancethe systematic detection, assessment, understanding and prevention of adverse drug reactions. Currently pharmaceutical executives face a number of challenges in the area of pharmacovigilance.The full version of this report provides insights that can guide companies as they contemplate the actions they will take to create this framework and foster the culture necessary to support it.Click below to download this 4-page, 294KB white paper.